January 31, 2025 03:00 PM EST

Genentech joins suits against STD clinics it says get 'unlawful' 340B discounts

Nicole DeFeudis

Editor

Genentech is the latest drugmaker to sue the federal government over STD clinics it says are wrongfully receiving discounts through the federal 340B program. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Genentech joins suits against STD clinics it says get 'unlawful' 340B discounts

Nicole DeFeudis

Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

AbbVie executives bask in Skyrizi, Rinvoq successes as the drugs take up Humira's mantle

Updated: Novartis claims best earnings in years, validating shift to pure-play strategy

RFK Jr. evades questions on vaccines and autism in written responses to senators

After more deliberation, England agrees to pay for Vertex’s gene therapy for sickle cell disease

Celltrion looks to buy US facilities to sidestep potential Trump tariffs

Why the premier recruitment agency in the world is giving up recruiting, and sponsors should, too

Genen­tech joins suits against STD clin­ics it says get 'un­law­ful' 340B dis­counts

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Genentech joins suits against STD clinics it says get 'unlawful' 340B discounts